Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (4793)	7/12/1998 2:19:00 AM
From: Brander	Read Replies (1) \| Respond to of 7041

Good job Bill. You copied three of my 1000 plus posts on SI. You also did not post your statements that I was responding to, which were irresponsible distortions, just like you are doing here. As I just told you, I sold TXB for a profit. As I have said repeatedly on this thread, I do not have a position in ZONA. Vasomax might get approved and it might not. If it turns out to be an effective drug, I welcome its availability. I certainly don't agree with trying to destroy the company, like you seem to be trying to do. My discussion with you has nothing to do with where I stand on ZONA, TXB, or even FBNA. You distorted the facts concerning the patent and the clinical trials. Whether you turn out to be right or wrong concerning the ultimate fate of ZONA, you still distorted the facts. You did the same thing on TXB.